- Home
- RCUS vs WRLD Comparison
RCUS vs WRLD Comparison
Compare RCUS & WRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCUS
- WRLD
- Stock Information
- Founded
- RCUS 2015
- WRLD 1962
- Country
- RCUS United States
- WRLD United States
- Employees
- RCUS N/A
- WRLD N/A
- Industry
- RCUS Biotechnology: Pharmaceutical Preparations
- WRLD Finance: Consumer Services
- Sector
- RCUS Health Care
- WRLD Finance
- Exchange
- RCUS Nasdaq
- WRLD Nasdaq
- Market Cap
- RCUS 906.4M
- WRLD 825.5M
- IPO Year
- RCUS 2018
- WRLD 1991
- Fundamental
- Price
- RCUS $8.36
- WRLD $169.37
- Analyst Decision
- RCUS Buy
- WRLD
- Analyst Count
- RCUS 10
- WRLD 0
- Target Price
- RCUS $23.75
- WRLD N/A
- AVG Volume (30 Days)
- RCUS 1.2M
- WRLD 61.1K
- Earning Date
- RCUS 08-07-2025
- WRLD 07-25-2025
- Dividend Yield
- RCUS N/A
- WRLD N/A
- EPS Growth
- RCUS N/A
- WRLD 23.58
- EPS
- RCUS N/A
- WRLD 16.30
- Revenue
- RCUS $141,000,000.00
- WRLD $564,781,378.00
- Revenue This Year
- RCUS N/A
- WRLD N/A
- Revenue Next Year
- RCUS $28.73
- WRLD N/A
- P/E Ratio
- RCUS N/A
- WRLD $10.13
- Revenue Growth
- RCUS N/A
- WRLD N/A
- 52 Week Low
- RCUS $6.50
- WRLD $101.85
- 52 Week High
- RCUS $18.98
- WRLD $170.44
- Technical
- Relative Strength Index (RSI)
- RCUS 39.01
- WRLD 62.96
- Support Level
- RCUS $7.91
- WRLD $157.51
- Resistance Level
- RCUS $8.87
- WRLD $170.44
- Average True Range (ATR)
- RCUS 0.48
- WRLD 4.59
- MACD
- RCUS -0.14
- WRLD 0.37
- Stochastic Oscillator
- RCUS 8.24
- WRLD 77.41
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
About WRLD World Acceptance Corporation
World Acceptance Corp operates a small-loan consumer finance business. The company offers short-term small installment loans, medium-term larger installment loans, related credit insurance and ancillary products and services to individuals. It also offers income tax return preparation services to its loan customers and other individuals. The Company operates 1,024 branches in Alabama, Georgia, Idaho, Illinois, Indiana, Kentucky, Louisiana, Mississippi, Missouri, New Mexico, Oklahoma, South Carolina, Texas, Tennessee, Utah, and Wisconsin.